Pozzi M, Castagnola D, Cherubini F
Divisione di Ginecologia Oncologica, Istituto Regina Elena per lo Studio e la Cura dei Tumori, Roma.
Minerva Ginecol. 1993 May;45(5):251-4.
Nineteen patients with simple endometrial hyperplasia presenting metrorrhagia or menometrorrhagia were treated with 4 injections of Goserelin depot, one every 4 weeks. 12/19 patients were refractory after previous medical therapy. The treatment with Goserelin depot resulted in a complete remission of the symptoms, occurring within the first month of treatment and still present after a median follow-up of 12 months, and in the normalization of the histological profile. No patient experienced clinically relevant side effects.